Ascendis Pharmac

ASND

251.0700.39% ( -0.980 )

Closed: Jul 30, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Ascendis Pharmac(ASND) predict that the Revenue is 282.6 M (+158.6%), Miss estimate;the EBIT is 28.43 M (+125.2%), Beat estimate;the EPS is 11.17 (+753.3%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.28B158.60%

0.31B181.96%

-0.03B23.36%

EBITExceed expectations

0.03B125.21%

0.02B120.51%

+0.01B4.70%

EPSExceed expectations

11.1735753.30%

-0.091794.64%

+11.2652658.66%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD